MitoQ Upregulates CYP19A1 to Protect Dermal Papilla Cells from DHT-Induced Mitochondrial Dysfunction and Apoptosis in Androgenetic Alopecia
January 2026
in “
Biochemical Pharmacology
”
Studysummary This study investigated how the antioxidant MitoQ and the enzyme CYP19A1 influence mitochondrial function in androgenetic alopecia. In a mouse model, both CYP19A1 overexpression and MitoQ treatment improved mitochondrial health and reversed DHT-induced hair loss factors, suggesting potential therapeutic targets for this condition.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on sciencedirect.com →